In heterogeneous catalysis, the catalyst is in a different phase from the reactants. SDS of cas: 253-52-1, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 253-52-1, name is Phthalazine. In an article£¬Which mentioned a new discovery about 253-52-1
How often are orphan drugs orphaned by the thermochemical community?
Orphan drug products (e.g. drugs and biologics) in the United States are those that treat people with rare chronic diseases, often cancer or metabolic disease. The rare disease condition being treated by these orphan drugs must serve a patient population of less than 200,000 people in the U.S. in order to earn the orphan drug product title. Just as the disease conditions are seen as ?orphans,? so, we assert is the thermochemical understanding of the drugs themselves in terms of the chemical structures that define those drugs. This article illustrates this orphan thermochemical status for a recent series of orphan drugs.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 253-52-1, help many people in the next few years.SDS of cas: 253-52-1
Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N137 – PubChem